Daily non-political popular news in brief.

Benefit of cancer prevention surgery differs between women with BRCA1 and BRCA2 mutations

The surgical removal of the ovaries has been widely adopted as a cancer-risk-reducing strategy for women with either BRCA1 or BRCA2 mutations. A new multicenter study led by researchers at Memorial Sloan-Kettering Cancer Center is the first prospective examination of the impact of this procedure in which BRCA2 mutation carriers were analyzed separately from BRCA1 mutation carriers.

Read more »

Keywords: benefit, cancer, prevention, surgery, differs, women, brca1, brca2, mutations, differ, mutation

« Previous | Next »

Similar news on "Benefit of cancer prevention surgery differs between women with BRCA1 and BRCA2 mutations":

1. Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene
   01-01-2008 · EurekAlert!
   Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations. After up to nine years of follow-up, BRCA1/2 mutation carriers were 28 percent less likely to die from the disease, even though women with the BRCA mutations are significantly more likely to develop ovarian and breast cancers.
   Similar news · Read more »
   
2. Breast cancer risk varies among women who are carriers of BRCA1 and BRCA2 gene mutations
   01-08-2008 · EurekAlert!
   Breast cancer risk varies widely among women who are carriers of the BRCA1 and BRCA2 mutations, according to a new study published in the Jan. 9, 2008, issue of the Journal of the American Medical Association.
   Similar news · Read more »
   
3. Personalized medicine can cut breast cancer risk
   02-15-2008 · EurekAlert!
   The time has come for breast cancer risk assessment, counseling and genetic testing to move from cancer specialists to the realm of primary care. A growing body of evidence has documented the benefits of preventive measures for high-risk women including those with mutations in the BRCA1 and BRCA2 genes. Referral for cancer-risk assessment and BRCA testing in the primary care setting is a necessary step towards personalized medicine for women at risk.
   Similar news · Read more »
   
4. BRCA1 mutation linked to breast cancer stem cells
   01-31-2008 · EurekAlert!
   A new study may explain why women with a mutation in the BRCA1 gene face up to an 85 percent lifetime risk of breast cancer. Researchers from the University of Michigan Comprehensive Cancer Center found that BRCA1 plays a role in regulating breast stem cells, the small number of cells that might develop into cancers.
   Similar news · Read more »
   
5. More common associations found between BRCA1 and BRCA2 mutations and cancer
   12-05-2006 · EurekAlert!
   BRCA1 and BRCA2 mutations may be more common in the general population than previously reported and may be associated with ovarian, breast, testicular and pancreatic cancers, according to a study in the Dec. 6 issue of the Journal of the National Cancer Institute.
   Similar news · Read more »
   
6. Anthracyclines improve survival in HER2-positive breast cancer patients
   12-25-2007 · EurekAlert!
   Treatment with the class of chemotherapy drugs called anthracyclines improves survival in women with HER2-positive breast cancer who have previously had surgery, but it may not offer any benefit for women with HER2-negative tumors, according to a study published online Dec. 25 in the Journal of the National Cancer Institute.
   Similar news · Read more »
   
7. New radiation technique can greatly reduce painful skin burns in women with breast cancer
   11-06-2006 · EurekAlert!
   Breast cancer patients who undergo a new radiation technique called intensity modulated radiation therapy (IMRT) after surgery are three times less likely to have severe skin reactions from the treatment compared to standard radiation therapy, according to a study presented at the plenary session November 6, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia. The study is the first of its kind to show how recent dramatic improvements in radiation treatments directly benefit patients.
   Similar news · Read more »
   
8. Varying prevalence among ethnic groups of gene mutation that increases risk of breast cancer
   12-25-2007 · EurekAlert!
   Among several US racial/ethnic groups examined, Hispanic women were found to have the highest prevalence of the cancer-associated gene mutation BRCA1 at 3.5 percent, with Asian Americans having the lowest prevalence (0.5 percent), according to a study in the Dec. 26 issue of JAMA.
   Similar news · Read more »
   
9. Breast cancer risk varies significantly among BRCA1 and BRCA2 carriers
   01-08-2008 · EurekAlert!
   There is a broad variation in the risk of developing breast cancer among people who carry the BRCA1 and BRCA2 gene mutation, according to a study in the Jan. 9/16 issue of JAMA.
   Similar news · Read more »
   
10. Extra radiation dose prevents breast cancer return in young women
    10-29-2007 · EurekAlert!
    Women 40 years and younger with early-stage breast cancer who receive an additional high dose of radiation after undergoing breast-conserving surgery and standard radiation treatment are almost twice as likely to be free of cancer 10 years after treatment compared to those who don't receive the boost dose.
    Similar news · Read more »